Network with GlaxoSmithKline, Roche, Sanofi, Johnson&Johnson, Boehringer-Ingelheim and many more at SMi's eighth annual Adaptive Designs in Clinical Trials conference

Share Article

Hear first-hand from organisations that have recently made breakthroughs in adaptive designs.

News Image

SMi invites you to attend the eighth annual Adaptive Designs in Clinical Trials conference, held in central London on the 24 & 25 March 2014.

You should attend this event if you work as a Director, Chief Executive, Chief Scientific Officer, Vice President, Head of Department, Principal Scientist or Statistician within the Pharmaceutical or Healthcare industry with responsibilities in the following areas:

  •     Biostatistics
  •     Adaptive Trials Design
  •     Regulatory Affairs
  •     Clinical Drug Development
  •     Contract Research
  •     Clinical Operations
  •     Research and Development
  •     Intellectual Property
  •     Legislation & Policy Advice
  •     Drug and Safety Assessment
  •     Clinical Pharmacology
  •     Experimental Medicine
  •     Clinical Trials
  •     Business Development

This event will analyse through case studies how all sizes of pharmaceutical companies have successfully implemented trials incorporating adaptive designs. This is the only conference in Europe that focuses on adaptive designs specifically and attendees will:

  •     Benefit from the first-hand experiences of speakers whose organisations have recently made breakthroughs in adaptive designs
  •     Hear the very latest on predicative analytical techniques for increasing efficiency of drug development
  •     Learn how to develop a normal standing clinical trial in an adaptive trial
  •     Discover FACT software that supports the ever-increasing complexity of adaptive clinical trials by attending the post-conference workshop

Key speakers include:

  • Michael Krams, MD, Global Head, Quantitative Sciences, Janssen Pharmaceutical Companies of Johnson & Johnson
  • Roger Lewis, MD, PhD, Senior Medical Scientist, Berry Consultants
  • Loïc Darchy, Head of Statistical Methodology Group, Sanofi R&D
  • Lilla Di Scala, Senior Statistical Scientist, Roche
  • Pantelis Vlachos, Principle Biostatistician, Strategic Consulting, Cytel Corporation
  • Sue Todd, Professor of Medical Statistics, University of Reading
  • Frank Fleisher, Principal Statistician, Boehringer-Ingelheim
  • Christopher Jennison, Professor of Statistics, University of Bath
  • Graeme Archer, Statistics Director, GlaxoSmithKline

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sonal Patel

Sonal Patel
SMi Group Ltd
Email >
Visit website